Current
Cyted
Life Sciences
•
East of England
•
Early Stage
•
2023
Cyted is a medical diagnostics company, that develops an innovative platform (combining a non-invasive test with data-driven biomarkers) for early detection and risk stratification of cancers and inflammatory diseases. Its first application is in the early detection of esophageal cancer for patients in primary and community care.
Looking for funding?
We’ve already helped hundreds of ambitious businesses in the UK and Ireland to accelerate their growth. If you’re looking for a minority investment partner that can provide long-term, flexible funding and support, please get in touch with our team today.
